rs770137596
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001184880.2(PCDH19):c.3341G>C(p.Arg1114Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000455 in 1,097,899 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1114H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 9Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001184880.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | NM_001184880.2 | MANE Select | c.3341G>C | p.Arg1114Pro | missense | Exon 6 of 6 | NP_001171809.1 | ||
| PCDH19 | NM_001105243.2 | c.3200G>C | p.Arg1067Pro | missense | Exon 5 of 5 | NP_001098713.1 | |||
| PCDH19 | NM_020766.3 | c.3197G>C | p.Arg1066Pro | missense | Exon 5 of 5 | NP_065817.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | ENST00000373034.8 | TSL:1 MANE Select | c.3341G>C | p.Arg1114Pro | missense | Exon 6 of 6 | ENSP00000362125.4 | ||
| PCDH19 | ENST00000255531.8 | TSL:1 | c.3200G>C | p.Arg1067Pro | missense | Exon 5 of 5 | ENSP00000255531.7 | ||
| PCDH19 | ENST00000420881.6 | TSL:1 | c.3197G>C | p.Arg1066Pro | missense | Exon 5 of 5 | ENSP00000400327.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD2 exomes AF: 0.0000220 AC: 4AN: 181623 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.00000455 AC: 5AN: 1097899Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 2AN XY: 363255 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 1114 of the PCDH19 protein (p.Arg1114Pro). This variant is present in population databases (rs770137596, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 581970). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at